INCOGNITO™ iPSCMax™ Ψ-mRNA Reprogramming Mix

About CELLSCRIPT

CELLSCRIPT is a long-standing, private biotechnology tools company that has positioned itself as a critical enabler of the mRNA revolution. The company provides a comprehensive suite of reagents and kits for in vitro transcription, 5' capping (including high-efficiency Cap 1), 3' poly(A) tailing, dsRNA removal, and mRNA quality analysis. While primarily a research products and services business, its technologies are foundational for clinical research, immunotherapy, and mRNA therapeutic/vaccine development, making it a key supplier to the broader biotech and pharma ecosystem. Its focus on reducing mRNA immunogenicity and improving translation efficiency aligns directly with the needs of next-generation RNA-based medicines.